| Cat. No. | Product Name | Information | 
            
                
            	| PC-47010 | TXY436 FtsZ inhibitor | TXY436 is an N-Mannich base derivative and FtsZ-directed prodrug of PC190723, TXY436 is effective against S. aureus can also target Gram-negative bacteria, such as Escherichia coli. | 
            
                
            	| PC-38782 | MMV652103 PIK3C2G inhibitor | MMV652103 is an antimalarial imidazopyridazine compound, exerts potent and selective cytotoxicity in ER+ breast cancer cells, potently inhibits the oncogenic PI4KB and PIK3C2G lipid kinases with IC50 of 1.7 and 0.085 uM, respectively. | 
            
                
            	| PC-38713 | KSK67 PrfA inhibitor | KSK67 is a potent small molecule inhibitor of bacterial transcriptional activator PrfA with IC50 of 67 nM, reduces virulence factor expression in L. monocytogene. | 
            
                
            	| PC-38712 | NSC116565 Mtb KARI inhibitor | NSC116565 is a potent, time-dependent inhibitor of Mycobacterium tuberculosis (M.tb) ketol-acid reductoisomerase (KARI) with Ki of 95.4 nM. | 
            
                
            	| PC-38648 | IITR06144 Antibiotic | IITR06144 is a novel nitrofuran and exhibits broad-spectrum bactericidal activity against most MDR bacteria (MIC, 0.5 mg/mL). | 
            
                
            	| PC-38637 | HSGN-94 LTA biosynthesis inhibitor | HSGN-94 is a potent lipoteichoic acid (LTA) biosynthesis inhibitor via direct binding to PgcA and downregulation of PgsA, exhibits potent antibacterial activity against both MRSA and VRE with MICs of 0.25 ug/mL. | 
            
                
            	| PC-38636 | HSGN-189 LTA biosynthesis inhibitor | HSGN-189 is a potent lipoteichoic acid (LTA) biosynthesis inhibitor, exhibits potent antibacterial activity against both MRSA and VRE strains with MICs of 1 ug/mL. | 
            
                
            	| PC-38634 | SMARt751 M.tb VirS Ligand | SMARt751 is a small molecule that interacts with the transcriptional regulator VirS of M. tuberculosis, up-regulates expression of the mymA operon, reverses resistance to ethionamide both in vitro and in vivo. | 
            
                
            	| PC-38633 | GSK2556286 M.tb inhibitor | GSK2556286 (GSK286) a novel inhibitor of M. tuberculosis extracellularly in the presence of cholesterol and within human macrophages, inhibits growth within human macrophages with IC50 of 70 nM (H37Rv in THP-1 cells). | 
            
                
            	| PC-38560 | DU011 MprA inhibitor | DU011 is a noncanonical anti-infective agent and small-molecule inhibitor of capsule biogenesis, targets MprA (Kd=30 nM), a MarR family transcriptional repressor of multidrug efflux pumps, inhibits capsule expression in E. coli. | 
            
                
            	| PC-38554 | PKZ18-22 Antibiotic | PKZ18-22 is a potency improved analog of PKZ18, inhibitiong tRNA-regulated gene expression of gram-positive bacteria, shows MIC value of 8 ug/mL against S. aureus. | 
            
                
            	| PC-38553 | PKZ18 Antibiotic | PKZ18 is a small-molecule antibiotic inhibiting the in vivo transcription of glycyl-tRNA synthetase mRNA in gram-positive bacteria, aslo inhibits in vivo translation of the S. aureus threonyl-tRNA synthetase protein. |